Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice


Por: Royo-Bordonada, MA, Armario, P, Bejarano, JML, Pedro-Botet, J, Alvarez, FV, Elosua, R, Cuixart, CB, Cortes, O, Serrano, B, Babkowski, MC, Nunez, AG, Perez, A, Maiques, A, Nocito, AD, de Castro, A, Alegria, E, Baeza, C, Herranz, M, Sans, S, Campos, P

Publicada: 1 may 2017
Resumen:
The VI European Guidelines for Cardiovascular Prevention recommend combining population and high risk strategies with lifestyle changes as a cornerstone of prevention, and propose the SCORE function to quantify cardiovascular risk. The guidelines highlight disease specific interventions, and conditions as women, young people and ethnic minorities. Screening for subclinical atherosclerosis with noninvasive imaging techniques is not recommended. The guidelines distinguish four risk levels (very high, high, moderate and low) with therapeutic objectives for lipid control according to risk. Diabetes mellitus confers a high risk, except for subjects with type 2 diabetes with less than <10 years of evolution, without other risk factors or complications, or type I diabetes of short evolution without complications. The decision to start pharmacological treatment of arterial hypertension will depend on the blood pressure level and the cardiovascular risk, taking into account the lesion of target organs. The guidelines don't recommend antiplatelet drugs in primary prevention because of the increased bleeding risk. The low adherence to the medication requires simplified therapeutic regimes and to identify and combat its causes. The guidelines highlight the responsibility of health professionals to take an active role in advocating evidence-based interventions at the population level, and propose effective interventions, at individual and population level, to promote a healthy diet, the practice of physical activity, the cessation of smoking and the protection against alcohol abuse. (C) 2017 Published by Elsevier Espana, S.L.U. on behalf of SESPAS.

Filiaciones:
Royo-Bordonada, MA:
 Inst Salud Carlos III, Escuela Nacl Sanidad, Madrid, Spain

Armario, P:
 Soc Espanola Hipertens Liga Espanola Lucha HTA, Madrid, Spain

Bejarano, JML:
 Soc Espanola Med Familia & Comunitaria, Madrid, Spain

Pedro-Botet, J:
 Soc Espanola Arteriosclerosis, Madrid, Spain

Alvarez, FV:
 Soc Espanola Arteriosclerosis, Madrid, Spain

Elosua, R:
 Soc Espanola Epidemiol, Madrid, Spain

Cuixart, CB:
 Soc Espanola Med Familia & Comunitaria, Madrid, Spain

Cortes, O:
 Asociac Espanola Pediat Atenc Primaria, Madrid, Spain

Serrano, B:
 Soc Espanola Med & Seguridad Trabajo, Madrid, Spain

Babkowski, MC:
 Soc Espanola Med Interna, Madrid, Spain

Nunez, AG:
 Soc Espanola Neurol, Madrid, Spain

Perez, A:
 Soc Espanola Diabet, Madrid, Spain

Maiques, A:
 Soc Espanola Med Familia & Comunitaria, Madrid, Spain

Nocito, AD:
 Soc Espanola Med Atenc Primaria SEMERGEN, Madrid, Spain

de Castro, A:
 Soc Espanola Cardiol, Madrid, Spain

Alegria, E:
 Soc Espanola Cardiol, Madrid, Spain

Baeza, C:
 Soc Espanola Angiol & Cirugia Vasc, Madrid, Spain

Herranz, M:
 Federac Asociac Enfermeria Comunitaria & Atenc Pr, Madrid, Spain

Sans, S:
 Soc Espanola Salud Publ & Adm Sanitaria, Madrid, Spain

Campos, P:
 Serv Sociales & Igualdad, Minist Sanidad, Madrid, Spain
ISSN: 02139111





Gaceta Sanitaria
Editorial
ELSEVIER, 685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA, España
Tipo de documento: Article
Volumen: 31 Número: 3
Páginas: 255-268
WOS Id: 000400322500016
ID de PubMed: 28292529
imagen Gold

MÉTRICAS